Related Experiment Video
Updated: Aug 11, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet
Hiromi Sato1, Seiichi Ishida, Kyoko Toda
1Institute of Medicinal Molecular Design, Inc. (IMMD), 5-24-5 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. hiromis@immd.co.jp
Current Drug Discovery Technologies
|February 14, 2006
Summary
KeyMolnet is a new platform for drug discovery and life science research. It analyzes DNA microarray data to reveal biological mechanisms and potential drug targets, aiding in medical and pharmaceutical advancements.
Area of Science:
- Bioinformatics
- Molecular Biology
- Genomics
Background:
- DNA microarray technology generates vast gene expression data.
- Extracting meaningful biological insights from large datasets is challenging.
- Understanding gene expression relationships to biological function requires advanced tools.
Purpose of the Study:
- To introduce KeyMolnet, a comprehensive information platform for post-genome era research.
- To demonstrate novel approaches for analyzing biological mechanisms using DNA microarray data.
- To connect molecular networks with physiological phenomena and medical/drug information.
Main Methods:
- Development of KeyMolnet, an advanced tool for generating molecular networks.
- Application of KeyMolnet for mechanism analysis with DNA microarray time-series data.
- Investigating apoptosis induction in HL-60 cells treated with 12-O-tetradecanoylphorbol 13-acetate (TPA).
Main Results:
- KeyMolnet facilitates the generation of molecular networks on demand.
- The platform successfully connects molecular signaling to physiological and medical contexts.
- A potential mechanism for TPA-induced apoptosis in HL-60 cells was elucidated using KeyMolnet.
Conclusions:
- KeyMolnet provides practical approaches for biological mechanism research.
- The platform aids in extracting actionable information from complex gene expression data.
- KeyMolnet contributes to new discoveries in medicine, pharmaceuticals, and life sciences.
Related Concept Videos
02:34DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...